Jeffrey Bennett, MD, PhD

home / authors / jeffrey-bennett-md-phd

Articles

Blocking B Cells may be the Key to Controlling NMOSD Over Time

Blocking B Cells may be the Key to Controlling NMOSD Over Time

September 15th 2022
B-Cell Depletion and Long-Term Outcomes in NMOSD With Inebilizumab: Jeffrey Bennett, MD, PhD

B-Cell Depletion and Long-Term Outcomes in NMOSD With Inebilizumab: Jeffrey Bennett, MD, PhD

December 1st 2021

The professor of neurology at the University of Colorado provided insight on the data that reinforced the relationship between B-cell depletion and improved outcomes using inebilizumab (Uplizna; Horizon Therapeutics). [WATCH TIME: 2 minutes]

© 2023 MJH Life Sciences

All rights reserved.